Top news from the gaming industry.
**Rules:**
1. No news roundups, promotions or offers
2. No off-topic or low-effort content or comments
3. No illegal content or inflammatory language
4. No reposts
Top news from the gaming industry.
**Rules:**
1. No news roundups, promotions or offers
2. No off-topic or low-effort content or comments
3. No illegal content or inflammatory language
4. No reposts
>"Akili says the underlying technology of its AKL-TO1 product (marketed in the U.S. as EndeavorRx) is “disease agnostic” and may be used as treatment for a variety for a variety of conditions."
>"Akili says the underlying technology of its AKL-TO1 product (marketed in the U.S. as EndeavorRx) is “disease agnostic” and may be used as treatment for a variety for a variety of conditions."